CML HealthCare Licenses Phenomenome Cancer Tests | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CML HealthCare, a healthcare services provider that also provides lab testing services in Ontario, Canada, has licensed rights to commercialize Phenomenome Discoveries' blood tests to assess an individual's risk of cancer.

Saskatoon, Saskatchewan-based Phenomenome uses its metabolomic biomarker discovery platform and informatics research tools in developing its tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.